• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Angiokeratoma regression in a Fabry disease after treatment with agalsidase-beta: clinical effectiveness marker?

作者信息

Fauchais A L, Prey S, Ouatara B, Vidal E, Sparsa A

出版信息

J Eur Acad Dermatol Venereol. 2010 Jun;24(6):737-8. doi: 10.1111/j.1468-3083.2009.03455.x. Epub 2009 Nov 11.

DOI:10.1111/j.1468-3083.2009.03455.x
PMID:19925601
Abstract
摘要

相似文献

1
Angiokeratoma regression in a Fabry disease after treatment with agalsidase-beta: clinical effectiveness marker?法布里病患者经β-半乳糖苷酶替代治疗后血管角质瘤消退：临床疗效标志物？
J Eur Acad Dermatol Venereol. 2010 Jun;24(6):737-8. doi: 10.1111/j.1468-3083.2009.03455.x. Epub 2009 Nov 11.
2
Safe and Successful Treatment With Agalsidase Beta During Pregnancy in Fabry Disease.法布里病患者孕期使用β-半乳糖苷酶进行安全且成功的治疗。
Iran J Kidney Dis. 2015 Sep;9(5):406-8.
3
Enzyme replacement therapy in two Japanese siblings with Fabry disease, and its effectiveness on angiokeratoma and neuropathic pain.法布瑞病两例日本兄妹的酶替代治疗及其对血管角质瘤和神经痛的疗效。
Mol Genet Metab. 2013 Nov;110(3):405-10. doi: 10.1016/j.ymgme.2013.07.005. Epub 2013 Jul 14.
4
Treatment with agalsidase beta during pregnancy in Fabry disease.法布里病患者孕期使用β-半乳糖苷酶治疗。
J Obstet Gynaecol Res. 2010 Apr;36(2):428-9. doi: 10.1111/j.1447-0756.2009.01164.x.
5
Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients with Fabry Disease.酶替代疗法和抗药抗体对法布里病患者的影响。
J Am Soc Nephrol. 2018 Sep;29(9):2265-2278. doi: 10.1681/ASN.2018030329. Epub 2018 Aug 9.
6
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry.接受阿加糖酶β治疗的成年法布里病患者的治疗获益时间：来自法布里病注册研究的数据。
J Med Genet. 2016 Jul;53(7):495-502. doi: 10.1136/jmedgenet-2015-103486. Epub 2016 Mar 18.
7
Enzyme replacement therapy in Fabry disease: comparison of agalsidase alfa and agalsidase beta.法布里病的酶替代疗法：阿加糖酶α与阿加糖酶β的比较
Mol Genet Metab. 2008 Sep-Oct;95(1-2):114-5. doi: 10.1016/j.ymgme.2008.07.002. Epub 2008 Aug 12.
8
Fabry disease: clinical outcomes of agalsidase enzyme replacement therapies.法布里病：阿加糖酶替代疗法的临床疗效
Int J Clin Pract. 2007 Jul;61(7):1234-5; author reply 1235. doi: 10.1111/j.1742-1241.2007.01399.x.
9
Angiokeratomas and treatment with enzyme replacement therapy in a patient with Fabry disease.血管角质瘤和酶替代疗法治疗 Fabry 病患者。
Acta Dermatovenerol Alp Pannonica Adriat. 2020 Jun;29(2):89-91.
10
Beneficial effects of long-term enzyme replacement therapy in a child with Fabry disease.长期酶替代疗法对一名法布里病患儿的有益效果。
Int J Clin Pract. 2010 Jun;64(7):995. doi: 10.1111/j.1742-1241.2009.02323.x.

引用本文的文献

1
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts.酶替代疗法对男性法布里病患者临床结局的影响：欧洲专家小组的系统文献综述
Mol Genet Metab Rep. 2019 Feb 6;19:100454. doi: 10.1016/j.ymgmr.2019.100454. eCollection 2019 Jun.